Compare with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SHASUN PHARMA ALKEM LABORATORIES/
SHASUN PHARMA
 
P/E (TTM) x - 123.9 - View Chart
P/BV x 6.7 8.5 78.4% View Chart
Dividend Yield % 0.6 0.2 277.9%  

Financials

 ALKEM LABORATORIES   SHASUN PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
SHASUN PHARMA
Mar-14
ALKEM LABORATORIES/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,58994 1,686.8%   
Low Rs1,23246 2,701.8%   
Sales per share (Unadj.) Rs417.5214.2 194.9%  
Earnings per share (Unadj.) Rs56.35.3 1,055.0%  
Cash flow per share (Unadj.) Rs64.715.8 409.0%  
Dividends per share (Unadj.) Rs12.701.00 1,270.0%  
Dividend yield (eoy) %0.91.4 62.9%  
Book value per share (Unadj.) Rs292.953.3 549.2%  
Shares outstanding (eoy) m119.5756.62 211.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.40.3 1,035.3%   
Avg P/E ratio x25.113.1 191.3%  
P/CF ratio (eoy) x21.84.4 493.3%  
Price / Book Value ratio x4.81.3 367.4%  
Dividend payout %22.618.7 120.4%   
Avg Mkt Cap Rs m168,6533,958 4,261.4%   
No. of employees `000NANA-   
Total wages/salary Rs m9,1712,164 423.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m49,91512,127 411.6%  
Other income Rs m1,645229 717.3%   
Total revenues Rs m51,56112,356 417.3%   
Gross profit Rs m8,4821,009 840.6%  
Depreciation Rs m1,006594 169.4%   
Interest Rs m671415 161.6%   
Profit before tax Rs m8,451230 3,679.1%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606-73 -2,208.5%   
Profit after tax Rs m6,731302 2,228.0%  
Gross profit margin %17.08.3 204.2%  
Effective tax rate %19.0-31.7 -60.0%   
Net profit margin %13.52.5 541.3%  
BALANCE SHEET DATA
Current assets Rs m27,0626,884 393.1%   
Current liabilities Rs m15,3248,456 181.2%   
Net working cap to sales %23.5-13.0 -181.5%  
Current ratio x1.80.8 216.9%  
Inventory Days Days6762 107.9%  
Debtors Days Days41108 38.4%  
Net fixed assets Rs m12,6104,970 253.7%   
Share capital Rs m239113 211.0%   
"Free" reserves Rs m34,4902,875 1,199.7%   
Net worth Rs m35,0273,020 1,159.7%   
Long term debt Rs m1,2121,817 66.7%   
Total assets Rs m54,38713,347 407.5%  
Interest coverage x13.61.6 875.7%   
Debt to equity ratio x00.6 5.7%  
Sales to assets ratio x0.90.9 101.0%   
Return on assets %13.65.4 253.3%  
Return on equity %19.210.0 192.1%  
Return on capital %24.913.3 186.6%  
Exports to sales %12.946.4 27.9%   
Imports to sales %3.114.2 21.7%   
Exports (fob) Rs m6,4615,622 114.9%   
Imports (cif) Rs m1,5401,728 89.2%   
Fx inflow Rs m6,5635,843 112.3%   
Fx outflow Rs m3,0122,173 138.6%   
Net fx Rs m3,5523,669 96.8%   
CASH FLOW
From Operations Rs m7,259398 1,825.6%  
From Investments Rs m1,864-1,635 -114.0%  
From Financial Activity Rs m-9,2731,309 -708.6%  
Net Cashflow Rs m-15071 -210.7%  

Share Holding

Indian Promoters % 66.9 39.2 170.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 3.6 919.4%  
FIIs % 0.0 17.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 39.6 -  
Shareholders   68,381 20,750 329.5%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   VENUS REMEDIES  PROCTER & GAMBLE HEALTH  NOVARTIS  J.B.CHEMICALS  ORCHID PHARMA LTD  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Oct 18, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS